Navidea Biopharmaceuticals (NAVB) To Webcast Investor Briefing On Sentinel Lymph Node Biopsy In Head & Neck Cancers July 8, 2014
7/3/2014 6:41:28 AM
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced it will host a webcast of an investor briefing to discuss the role of sentinel lymph node biopsy in head and neck cancers on Tuesday, July 8, 2014 from 8:00 to 9:00 am EDT in New York City.
Help employers find you! Check out all the jobs and post your resume.
comments powered by